{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:46:17Z","timestamp":1792039577223,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofhospitalinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jhin.2026.09.022","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:21:54Z","timestamp":1790137314000},"page":"8-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Divergent epidemic trajectories of ESBL-producing and carbapenemase-producing Enterobacterales in French hospitals: a nationwide modelling study"],"prefix":"10.1016","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2859-8417","authenticated-orcid":false,"given":"Benjamin","family":"Davido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9064-361X","authenticated-orcid":false,"given":"Louise","family":"Rouillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9035-4417","authenticated-orcid":false,"given":"Pierre","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maelys","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4585-7989","authenticated-orcid":false,"given":"Azzam","family":"Saleh-Mghir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2026.09.022_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jhin.2026.09.022_bib2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jhin.2026.09.022_bib4","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jac\/dks429","article-title":"10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum -lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre","volume":"68","author":"Nicolas-Chanoine","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2026.09.022_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1473-3099(16)30319-X","article-title":"Import and spread of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study","volume":"17","author":"Arcilla","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhin.2026.09.022_bib6","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3201\/eid1710.110655","article-title":"Global spread of Carbapenemase-producing Enterobacteriaceae","volume":"17","author":"Nordmann","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jhin.2026.09.022_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlac048","article-title":"Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli between healthcare and community settings: a systematic review and meta-analysis","volume":"4","author":"Bezabih","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.jhin.2026.09.022_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.48.1.15-22.2004","article-title":"Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae","volume":"48","author":"Poirel","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2026.09.022_bib9","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/jac\/dks121","article-title":"OXA-48-like carbapenemases: the phantom menace","volume":"67","author":"Poirel","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2026.09.022_bib10","article-title":"The global ascendency of OXA-48-type carbapenemases","volume":"33","author":"Pitout","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jhin.2026.09.022_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/JCM.02234-12","article-title":"Emergence of OXA-48 and OXA-181 Carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract","volume":"51","author":"Brink","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhin.2026.09.022_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00314","article-title":"Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) among carbapenem-resistant Enterobacteriaceae isolated from adult and children patients in China","volume":"10","author":"Han","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jhin.2026.09.022_bib13","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.31.20549","article-title":"Intercontinental spread of OXA-48 beta-lactamase-producing enterobacteriaceae over a 11-year period, 2001 to 2011","volume":"18","author":"Potron","year":"2013","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jhin.2026.09.022_bib14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijantimicag.2015.03.005","article-title":"Forecasting carbapenem resistance from antimicrobial consumption surveillance: lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit","volume":"46","author":"Gharbi","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jhin.2026.09.022_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00274-25","article-title":"Dissemination of ESBL-producing Escherichia coli and carriage in the community worldwide: epidemiology, transmission pathways, molecular insights, and practical aspects","author":"Beaumont","year":"2026","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jhin.2026.09.022_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01090-21","article-title":"Recent emergence of aztreonam-avibactam resistance in NDM and OXA-48 carbapenemase-producing Escherichia coli in Germany","volume":"65","author":"Nordmann","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2026.09.022_bib17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ijantimicag.2019.09.007","article-title":"Ceftazidime\/avibactam versus carbapenems for the treatment of infections caused by Enterobacteriaceae: a meta-analysis of randomised controlled trials","volume":"54","author":"Che","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jhin.2026.09.022_bib18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12879-017-2383-z","article-title":"Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis","volume":"17","author":"Zilberberg","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhin.2026.09.022_bib19","first-page":"342","article-title":"Consommation d\u2019antibiotiques et r\u00e9sistances bact\u00e9riennes en \u00e9tablissement de sant\u00e9. Donn\u00e9es Spares 2020","volume":"18\u201319","author":"Chabaud","year":"2021","journal-title":"Bull Epid\u00e9miol Hebd"},{"key":"10.1016\/j.jhin.2026.09.022_bib20","series-title":"Surveillance de la consommation des antibiotiques, des antifongiques et des r\u00e9sistances bact\u00e9riennes en \u00e9tablissement de sant\u00e9. Mission SPARES. R\u00e9sultats 2024","first-page":"1","year":"2026"},{"key":"10.1016\/j.jhin.2026.09.022_bib22","series-title":"Global antibiotic resistance surveillance report 2025 WHO global antimicrobial resistance and use surveillance system (GLASS)","year":"2025"},{"key":"10.1016\/j.jhin.2026.09.022_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antinf.2017.01.004","article-title":"Antibiotic resistance in the community: Myth or reality? The threat of ESBL producing enterobacteria","volume":"19","author":"Armand-Lef\u00e8vre","year":"2017","journal-title":"J Des Anti-Infectieux"},{"key":"10.1016\/j.jhin.2026.09.022_bib24","article-title":"Estimating the number and incidence of carbapenemase-producing Enterobacterales infections in France in 2020: a capture-recapture study","volume":"55","author":"Colomb-Cotinat","year":"2025","journal-title":"Infect Dis Now"},{"key":"10.1016\/j.jhin.2026.09.022_bib26","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.46234\/ccdcw2022.222","article-title":"National antibiotic resistance strategy for human health in France","volume":"4","author":"Pulcini","year":"2022","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.jhin.2026.09.022_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhin.2026.09.022_bib28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum \u03b2-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jhin.2026.09.022_bib29","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1128\/AAC.49.10.4423-4424.2005","article-title":"Plasmid-mediated carbapenem-hydrolyzing \u03b2-lactamase KPC in a Klebsiella pneumoniae isolate from France","volume":"49","author":"Naas","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2026.09.022_bib30","doi-asserted-by":"crossref","first-page":"9522","DOI":"10.1038\/s41467-025-64515-7","article-title":"Plasmid dynamics driving carbapenemase gene dissemination in healthcare environments: a nationwide analysis of closed Enterobacterales genomes","volume":"16","author":"Koh","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhin.2026.09.022_bib31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/1469-0691.12325","article-title":"High rate of faecal carriage of extended-spectrum \u03b2-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco","volume":"20","author":"Girlich","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2026.09.022_bib32","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/1469-0691.12719","article-title":"The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide","volume":"20","author":"Nordmann","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2026.09.022_bib33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41467-025-66874-7","article-title":"The rise and global spread of IMP carbapenemases (1996-2023): a genomic epidemiology study","volume":"17","author":"Vezina","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhin.2026.09.022_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlag099","article-title":"Carbapenemases: epidemiology, detection and management in a changing global landscape","volume":"8","author":"Macesic","year":"2026","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.jhin.2026.09.022_bib35","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.3201\/eid2710.211265","article-title":"New Delhi metallo-\u03b2-lactamase\u2013producing Enterobacterales bacteria, Switzerland, 2019\u20132020","volume":"27","author":"Findlay","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jhin.2026.09.022_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13756-026-01766-z","article-title":"Long-term dissemination of NDM-producing Enterobacterales in two French hospitals (2020\u20132024): outbreak complexity and the role of drains as environmental reservoirs","volume":"15","author":"M\u00e9nard","year":"2026","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jhin.2026.09.022_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2026.09.022_bib38","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/jac\/dkr053","article-title":"Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae","volume":"66","author":"T\u00e4ngd\u00e9n","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2026.09.022_bib39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1179\/joc.2011.23.6.341","article-title":"Impact of ceftriaxone de-restriction on the occurrence of ESBL-positive bacterial strains and antibiotic consumption","volume":"23","author":"Skrlin","year":"2011","journal-title":"J Chemother"},{"key":"10.1016\/j.jhin.2026.09.022_bib40","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1086\/322677","article-title":"Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli","volume":"33","author":"Harbarth","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2026.09.022_bib41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijantimicag.2015.03.005","article-title":"Forecasting carbapenem resistance from antimicrobial consumption surveillance: lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit","volume":"46","author":"Gharbi","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jhin.2026.09.022_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2026.107890","article-title":"Antibiotic consumption in Europe, 2019\u20132024: being AWaRe is not about using less","volume":"67","author":"Leroux","year":"2026","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jhin.2026.09.022_bib43","first-page":"465","article-title":"Consommation d\u2019antibiotiques et r\u00e9sistances bact\u00e9riennes en \u00e9tablissement de sant\u00e9. Donn\u00e9es Spares 2019-2022","volume":"22","author":"Dumartin","year":"2023","journal-title":"Bull \u00c9pid\u00e9miol Hebd"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670126003798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670126003798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:05:04Z","timestamp":1792037104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670126003798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":40,"alternative-id":["S0195670126003798"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2026.09.022","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Divergent epidemic trajectories of ESBL-producing and carbapenemase-producing Enterobacterales in French hospitals: a nationwide modelling study","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2026.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of The Healthcare Infection Society.","name":"copyright","label":"Copyright"}]}}